Research Article

Pan-Cancer Analysis of Microfibrillar-Associated Protein 2 (MFAP2) Based on Bioinformatics and qPCR Verification

Table 2

MFAP2 expression in cancers versus normal tissue in Oncomine database.

CancerCancer typeP-valueFold changeRank (%)SampleReference (PMID)

BladderInfiltrating bladder urothelial carcinoma1.51E–72.3277%15716432078
BladderInfiltrating bladder urothelial carcinoma6.46E–53.19210%6015173019
Breast cancerInvasive ductal breast carcinoma6.80E–54.2651%3017389037
Breast cancerInvasive ductal breast carcinoma8.43E–133.7001%6415034139
Breast cancerLobular breast carcinoma3.33E–73.4962%6415034139
Breast cancerDuctal breast carcinoma in situ stroma5.81E–52.8822%6619187537
Breast cancerTubular breast carcinoma3.32E–272.3902%2,13622522925
Breast cancerInvasive ductal and invasive lobular breast carcinoma3.47E–232.0015%2,13622522925
Breast cancerMedullary breast carcinoma4.21E–82.0578%2,13622522925
Breast cancerDuctal breast carcinoma6.05E–64.7535%4716473279
Colorectal cancerColon mucinous adenocarcinoma4.97E–84.4131%10517615082
Colorectal cancerCecum adenocarcinoma3.86E–83.1352%10517615082
Colorectal cancerRectosigmoid adenocarcinoma5.22E–63.6302%10517615082
Colorectal cancerColon adenocarcinoma2.69E–83.4854%10517615082
Colorectal cancerColorectal carcinoma4.42E–124.4751%10520957034
Colorectal cancerColon carcinoma3.04E–103.5392%4020957034
Colorectal cancerColon carcinoma epithelia5.76E–72.2706%4020957034
Colorectal cancerRectal adenocarcinoma1.12E–284.3062%13020725992
Esophageal cancerEsophageal squamous cell carcinoma7.35E–253.2461%10621385931
Esophageal cancerEsophageal squamous cell carcinoma3.44E–85.1122%3420955586
Gastric cancerGastric cancer5.99E–76.1071%2721132402
Gastric cancerGastric adenocarcinoma6.48E–52.2381%9021447720
Gastric cancerDiffuse gastric adenocarcinoma7.33E–82.5621%9021447720
Gastric cancerGastric intestinal type adenocarcinoma6.67E–62.6561%9021447720
Gastric cancerGastric cancer1.29E–83.5631%16020965966
Gastric cancerDiffuse gastric adenocarcinoma1.12E–63.2642%13212925757
Gastric cancerGastric mixed adenocarcinoma1.09E–54.7782%13212925757
Gastric cancerGastric intestinal type adenocarcinoma4.03E–132.9473%13212925757
Gastric cancerGastric intestinal type adenocarcinoma7.03E–126.9682%6919081245
Gastric cancerGastric mixed adenocarcinoma1.69E–58.7803%6919081245
Head and neck cancerHead and neck squamous cell carcinoma1.82E–164.9131%3814676830
Head and neck cancerSalivary gland adenoid cystic carcinoma2.54E–83.5101%2212368205
Head and neck cancerHead and neck squamous cell carcinoma8.79E–146.3811%5414729608
Head and neck cancerOral cavity squamous cell carcinoma epithelia7.56E–52.0972%2015381369
Head and neck cancerOral cavity squamous cell carcinoma1.17E–152.6212%7921853135
Head and neck cancerTongue carcinoma2.45E–52.7546%8417510386
Lung cancerLung adenocarcinoma2.63E–92.4435%15620421987
Lung cancerSquamous cell lung carcinoma6.20E–82.8459%15620421987
Other cancerYolk sac tumor, NOS3.64E–116.5211%10716424014
Other cancerMixed germ cell tumor, NOS4.87E–164.1891%10716424014
Other cancerTeratoma, NOS5.23E–85.7054%10716424014
Other cancerUterine corpus leiomyoma2.49E–103.3211%7719622772
Other cancerSkin basal cell carcinoma1.65E–78.1191%8718442402
Other cancerMalignant fibrous histiocytoma1.30E–610.3422%5415994966
Other cancerPleural malignant mesothelioma1.63E–55.2983%5415920167
Ovarian cancerOvarian carcinoma3.52E–83.3309%19518593951
Pancreatic cancerPancreatic ductal adenocarcinoma5.17E–174.1171%7819260470
SarcomaDedifferentiated liposarcoma3.74E–166.5141%15820601955
SarcomaMyxofibrosarcoma6.33E–114.6273%15820601955
SarcomaPleomorphic liposarcoma4.94E–83.5683%15820601955
SarcomaMyxoid/Round cell liposarcoma4.77E–92.9565%15820601955
SarcomaMalignant fibrous histiocytoma1.30E–610.3422%5415994966
SarcomaFibrosarcoma7.42E–613.6692%5415994966